FLGT
Income statement / Annual
Last year (2023), Fulgent Genetics, Inc.'s total revenue was $289.21 M,
a decrease of 53.27% from the previous year.
In 2023, Fulgent Genetics, Inc.'s net income was -$167.83 M.
See Fulgent Genetics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$289.21 M
|
$618.97 M
|
$992.58 M
|
$421.71 M
|
$32.53 M
|
$21.36 M
|
$18.73 M
|
$18.28 M
|
$9.58 M
|
$1.28 M
|
| Cost of Revenue |
$184.76 M |
$252.07 M |
$215.53 M |
$89.81 M |
$14.11 M |
$10.69 M |
$8.55 M |
$6.72 M |
$5.07 M |
$936,000.00 |
| Gross Profit |
$104.46 M |
$366.90 M |
$777.05 M |
$331.91 M |
$18.42 M |
$10.67 M |
$10.18 M |
$11.56 M |
$4.51 M |
$342,000.00 |
| Gross Profit Ratio |
0.36 |
0.59 |
0.78 |
0.79 |
0.57 |
0.5 |
0.54 |
0.63 |
0.47 |
0.27 |
| Research and Development
Expenses |
$41.44 M
|
$28.91 M
|
$24.22 M
|
$11.58 M
|
$6.54 M
|
$5.53 M
|
$4.22 M
|
$3.56 M
|
$4.43 M
|
$521,000.00
|
| General & Administrative
Expenses |
$89.00 M
|
$111.07 M
|
$50.73 M
|
$15.22 M
|
$6.41 M
|
$5.54 M
|
$5.13 M
|
$4.61 M
|
$2.42 M
|
$230,000.00
|
| Selling & Marketing
Expenses |
$41.47 M
|
$38.92 M
|
$24.44 M
|
$14.95 M
|
$5.90 M
|
$4.65 M
|
$4.22 M
|
$2.47 M
|
$2.67 M
|
$581,000.00
|
| Selling, General &
Administrative Expenses |
$130.47 M
|
$149.99 M
|
$75.17 M
|
$30.17 M
|
$12.31 M
|
$10.19 M
|
$9.36 M
|
$7.08 M
|
$5.09 M
|
$811,000.00
|
| Other Expenses |
$0.00 |
$6.50 M |
$1.71 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$171.91 M |
$185.40 M |
$101.10 M |
$41.75 M |
$18.85 M |
$15.72 M |
$13.58 M |
$10.64 M |
$9.52 M |
$1.33 M |
| Cost And Expenses |
$364.51 M |
$437.47 M |
$316.63 M |
$131.55 M |
$32.96 M |
$26.41 M |
$22.13 M |
$17.36 M |
$14.59 M |
$2.27 M |
| Interest Income |
$21.44 M |
$5.50 M |
$1.35 M |
$1.53 M |
$837,000.00 |
$434,000.00 |
$481,000.00 |
$1,000.00 |
$27,000.00 |
$0.00 |
| Interest Expense |
$0.00 |
$5.50 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$5.39 M |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$26.14 M
|
$36.91 M
|
$12.16 M
|
$3.37 M
|
$2.52 M
|
$2.16 M
|
$1.73 M
|
$1.17 M
|
$575,000.00
|
$196,000.00
|
| EBITDA |
-$46.55 M
|
$221.59 M
|
$675.95 M
|
$290.16 M
|
$1.68 M
|
-$2.91 M
|
-$1.75 M
|
$2.09 M
|
-$4.44 M
|
-$794,000.00
|
| EBITDA Ratio |
-0.16 |
0.31 |
0.68 |
0.69 |
-0.01 |
-0.24 |
-0.18 |
0.05 |
-0.46 |
-0.62 |
| Operating Income Ratio
|
-0.25
|
0.29
|
0.68
|
0.69
|
-0.01
|
-0.24
|
-0.18
|
0.05
|
-0.52
|
-0.77
|
| Total Other
Income/Expenses Net |
-$101.39 M
|
$5.50 M
|
$1.35 M
|
$1.53 M
|
$837,000.00
|
$434,000.00
|
$481,000.00
|
-$5.39 M
|
$27,000.00
|
$0.00
|
| Income Before Tax |
-$174.09 M |
$184.03 M |
$677.30 M |
$291.68 M |
$409,000.00 |
-$4.62 M |
-$2.92 M |
-$4.47 M |
-$4.99 M |
-$990,000.00 |
| Income Before Tax Ratio
|
-0.6
|
0.3
|
0.68
|
0.69
|
0.01
|
-0.22
|
-0.16
|
-0.24
|
-0.52
|
-0.77
|
| Income Tax Expense |
$1.15 M |
$42.10 M |
$174.80 M |
$72.53 M |
$43,000.00 |
-$1.07 M |
-$768,000.00 |
$920,000.00 |
$3.33 M |
$3.29 M |
| Net Income |
-$167.83 M |
$143.40 M |
$507.36 M |
$214.31 M |
$366,000.00 |
-$4.49 M |
-$2.66 M |
-$5.39 M |
-$8.31 M |
-$4.28 M |
| Net Income Ratio |
-0.58 |
0.23 |
0.51 |
0.51 |
0.01 |
-0.21 |
-0.14 |
-0.29 |
-0.87 |
-3.35 |
| EPS |
-5.63 |
4.76 |
17.13 |
9.64 |
0.0196 |
-0.25 |
-0.15 |
-0.3 |
-0.65 |
-0.34 |
| EPS Diluted |
-5.63 |
4.63 |
16.26 |
9.09 |
0.0196 |
-0.25 |
-0.15 |
-0.3 |
-0.65 |
-0.34 |
| Weighted Average Shares
Out |
$29.78 M
|
$30.10 M
|
$29.41 M
|
$22.69 M
|
$18.71 M
|
$17.98 M
|
$17.74 M
|
$17.68 M
|
$12.77 M
|
$12.77 M
|
| Weighted Average Shares
Out Diluted |
$29.78 M
|
$30.96 M
|
$30.98 M
|
$24.06 M
|
$18.71 M
|
$17.98 M
|
$17.74 M
|
$17.68 M
|
$12.77 M
|
$12.77 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
